- Page 1: ACCURACY OF TESTS FOR PREDICTING SP
- Page 5 and 6: Acknowledgements In undertaking thi
- Page 7 and 8: Table of contents Chapter 1 Thesis
- Page 9 and 10: Absence of fetal breathing movement
- Page 11 and 12: Figure 15 Forest plots of likelihoo
- Page 13 and 14: Figure 42 Forest plots of likelihoo
- Page 15 and 16: Figure 71 Forest plots of likelihoo
- Page 17 and 18: eference standards (outcome of spon
- Page 19 and 20: Table 18 Individual accuracy result
- Page 21 and 22: Table 48 Characteristics of test ac
- Page 23 and 24: labour. Literature was identified f
- Page 25 and 26: 8) strategies needs to be explored.
- Page 27 and 28: morbidities, which often lengthen h
- Page 29 and 30: anticipating a normal course of pre
- Page 31 and 32: The second population of interest i
- Page 33 and 34: Chapter 3 Methods Protocol developm
- Page 35 and 36: stage process using predefined and
- Page 37 and 38: Table 1 List of tests that purporte
- Page 39 and 40: corresponding authors so that only
- Page 41 and 42: Figure 2 Flow chart of procedures f
- Page 43 and 44: Figure 3 Identification of test acc
- Page 45 and 46: with one previous spontaneous prete
- Page 47 and 48: Figure 6 Plot of sensitivity agains
- Page 49 and 50: predicting spontaneous preterm birt
- Page 51 and 52: Figure 9 Forest plots of likelihood
- Page 53 and 54:
within 7-10 days of testing in addi
- Page 55 and 56:
Figure 10 Methodological quality of
- Page 57 and 58:
Figure 13 Plot of sensitivity again
- Page 59 and 60:
Figure 17 Forest plots of likelihoo
- Page 61 and 62:
Figure 20 Plot of sensitivity again
- Page 63 and 64:
Cervico-vaginal prolactin During pr
- Page 65 and 66:
Figure 23 Methodological quality of
- Page 67 and 68:
Figure 24 Forest plots of likelihoo
- Page 69 and 70:
women had reported spontaneous pret
- Page 71 and 72:
Figure 26 Methodological quality of
- Page 73 and 74:
Figure 29 Forest plots of likelihoo
- Page 75 and 76:
Serum α-fetoprotein (MSAFP) A high
- Page 77 and 78:
Figure 32 Methodological quality of
- Page 79 and 80:
Figure 36 Plot of sensitivity again
- Page 81 and 82:
Accuracy of maternal serum relaxin
- Page 83 and 84:
Figure 38 Forest plots of likelihoo
- Page 85 and 86:
Only two studies used the same thre
- Page 87 and 88:
β-human chorionic gonadotrophin (
- Page 89 and 90:
showed asymmetry indicating presenc
- Page 91 and 92:
Figure 42 Forest plots of likelihoo
- Page 93 and 94:
Estriol Estriol is produced by both
- Page 95 and 96:
Figure 46 Methodological quality of
- Page 97 and 98:
Figure 47 Forest plots of likelihoo
- Page 99 and 100:
while for symptomatic women with th
- Page 101 and 102:
Figure 48 Methodological quality of
- Page 103 and 104:
Figure 51 Forest plots of likelihoo
- Page 105 and 106:
Interleukin-6 (IL6) Interleukin 6 (
- Page 107 and 108:
Figure 53 Methodological quality of
- Page 109 and 110:
epresented the largest higher quali
- Page 111 and 112:
Figure 54 Forest plots of likelihoo
- Page 113 and 114:
Figure 57 Plot of sensitivity again
- Page 115 and 116:
two-weekly interval. For symptomati
- Page 117 and 118:
Figure 58 Methodological quality of
- Page 119 and 120:
Matrix metalloproteases-9 (MMP-9) D
- Page 121 and 122:
Figure 61 Forest plots of likelihoo
- Page 123 and 124:
All but one study assessed women’
- Page 125 and 126:
Figure 63 Forest plots of likelihoo
- Page 127 and 128:
Asymptomatic bacteriuria assessment
- Page 129 and 130:
Figure 66 Methodological quality of
- Page 131 and 132:
Figure 68 Plot of sensitivity again
- Page 133 and 134:
Gram staining using Spiegel’s 232
- Page 135 and 136:
Figure 70 Methodological quality of
- Page 137 and 138:
Figure 73 Plot of sensitivity again
- Page 139 and 140:
Mammary stimulation test Antenatal
- Page 141 and 142:
Uterine activity monitoring Presenc
- Page 143 and 144:
Accuracy of uterine activity monito
- Page 145 and 146:
Rheobase Rheobase in the context of
- Page 147 and 148:
Absence of fetal breathing movement
- Page 149 and 150:
Figure 84 Forest plots of likelihoo
- Page 151 and 152:
Cervical ultrasound assessment Ante
- Page 153 and 154:
Figure 87 Methodological quality of
- Page 155 and 156:
Accuracy of cervical length and fun
- Page 157 and 158:
Figure 88 Forest plots of likelihoo
- Page 159 and 160:
Figure 92 Forest plots of likelihoo
- Page 161 and 162:
Figure 96 Forest plots of likelihoo
- Page 163 and 164:
gestation or birth with 48 hours of
- Page 165 and 166:
The main accuracy results are summa
- Page 167 and 168:
Figure 100 Summary forest plots of
- Page 169 and 170:
Screening typically involves use of
- Page 171 and 172:
Table 3 Summary of tests’ accurac
- Page 173 and 174:
Table 5 Summary of tests’ accurac
- Page 175 and 176:
Chapter 6 Discussion Methodological
- Page 177 and 178:
completely as would have been desir
- Page 179 and 180:
antenatal women population, using a
- Page 181 and 182:
final common pathway of spontaneous
- Page 183 and 184:
effectiveness), there are no practi
- Page 185 and 186:
Recommendations for research • Ne
- Page 187 and 188:
modelling project should make provi
- Page 189 and 190:
188
- Page 191 and 192:
Appendix II - Search strategies MED
- Page 193 and 194:
111. (premature adj3 rupture adj3 m
- Page 195 and 196:
92. Granuloma Inguinale/ 93. mycopl
- Page 197 and 198:
s (oncofetal or c-reactive)(w)(prot
- Page 199 and 200:
s (uterine or antepartum)(3w)(hemor
- Page 201 and 202:
interpregnancy and interval* or occ
- Page 203 and 204:
((((physical next exam) or (physica
- Page 205 and 206:
Appendix IV - Characteristics and r
- Page 207 and 208:
Table 12 Characteristics of test ac
- Page 209 and 210:
Table 13 Individual accuracy result
- Page 211 and 212:
Table 14 Characteristic of studies
- Page 213 and 214:
Symptomatic Luzzi 110 2003 133 Coho
- Page 215 and 216:
Peaceman 79 1997 725 Cohort Prospec
- Page 217 and 218:
Rozenberg 128 1997 76 Calda 120 199
- Page 220 and 221:
Table 16 Individual accuracy result
- Page 222 and 223:
Table 18 Individual accuracy result
- Page 224 and 225:
Elizur 144 2005 35 Cohort Prospecti
- Page 226 and 227:
Table 21 Characteristics of the inc
- Page 228 and 229:
Table 22 Individual accuracy result
- Page 230 and 231:
Table 23 Characteristics of studies
- Page 232 and 233:
Table 25 Characteristics of studies
- Page 234 and 235:
Table 27 Characteristics of the inc
- Page 236 and 237:
Liu 183 1999 USA 72 Case-control Re
- Page 238 and 239:
Table 29 Characteristics of studies
- Page 240 and 241:
Table 31 Characteristic of studies
- Page 242 and 243:
*TP = true positive, FP = false pos
- Page 244 and 245:
Table 34 Characteristics of the inc
- Page 246 and 247:
Silver 219 1993 USA 29 Cohort Prosp
- Page 248 and 249:
Turhan 230 2000 Turkey 82 Cohort Pr
- Page 250 and 251:
34 weeks Rizzo 1 217 18 0 34 40 0.3
- Page 252 and 253:
Table 37 Individual accuracy result
- Page 254 and 255:
Table 40 Characteristics of the inc
- Page 256 and 257:
Table 41 Individual accuracy result
- Page 258 and 259:
Stuart 273 1965 UK 817 Case-control
- Page 260 and 261:
Table 43 Individual accuracy result
- Page 262 and 263:
Table 44 Characteristics of the inc
- Page 264 and 265:
Helou, 1996 292 Israel Cohort Blind
- Page 266 and 267:
Krohn, 1991 302 USA Prospective Tes
- Page 268 and 269:
Holst 232 Spiegel 9 3 13 24 0.41 0.
- Page 270 and 271:
Table 48 Characteristics of test ac
- Page 272 and 273:
Table 50 Characteristic of studies
- Page 274 and 275:
Castle 312 1983 English Cohort Pros
- Page 276 and 277:
Table 54 Characteristics of test ac
- Page 278 and 279:
Table 55 Characteristics of test ac
- Page 280 and 281:
Table 56 Characteristics of test ac
- Page 282 and 283:
Table 57 Individual accuracy result
- Page 284 and 285:
Table 58 Individual accuracy result
- Page 286 and 287:
Table 59 Individual accuracy result
- Page 288 and 289:
Another method for assessing hetero
- Page 290 and 291:
Publications directly contributing
- Page 292 and 293:
15. Martin JA, Hamilton BE, Sutton
- Page 294 and 295:
44. Honest H, Bachmann LM, Knox EM,
- Page 296 and 297:
72. Parikh MN,.Mehta AC. Internal c
- Page 298 and 299:
99. Vercoustre L, Sotter S, Bouige
- Page 300 and 301:
126. Pieta-Dolinska A, Jaczewski B,
- Page 302 and 303:
preterm delivery but not with fetal
- Page 304 and 305:
and activin A in maternal serum: pr
- Page 306 and 307:
199. Foulon W, Van Liedekerke D, De
- Page 308 and 309:
223. Kurkinen-Raty M, Ruokonen A, V
- Page 310 and 311:
249. Radnai M, Gorzo I, Nagy E, Urb
- Page 312 and 313:
281. Spiegel CA, Amsel R, Eschenbac
- Page 314 and 315:
307. Guinn DA, Wigton TR, James JA,
- Page 316 and 317:
334. Daskalakis G, Thomakos N, Hatz